Moclobemide and selegeline in the treatment of depression in Parkinson's diseaseSTEUR, E. N. H. J; BALLERING, L. A. P.Journal of neurology, neurosurgery and psychiatry. 1997, Vol 63, Num 4, issn 0022-3050, p. 547Article

Decreased concentration of annexin v in parkinsonian cerebrospinal fluid : Speculation on the underlying causeVERMES, I; STEUR, E. N. H. J; REUTELINGSPERGER, C et al.Movement disorders. 1999, Vol 14, Num 6, pp 1008-1010, issn 0885-3185Article

Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patientsBURGHAUS, L; SCHÜTZ, U; KREMPEL, U et al.Molecular brain research. 2000, Vol 76, Num 2, pp 385-388, issn 0169-328XArticle

Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's diseaseFARKAS, E; DE JONG, G. I; DE VOS, R. A. I et al.Acta neuropathologica. 2000, Vol 100, Num 4, pp 395-402, issn 0001-6322Article

Parkinson's disease : affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor systemBRAAK, H; RÜB, U; SANDMANN-KEIL, D et al.Acta neuropathologica. 2000, Vol 99, Num 5, pp 489-495, issn 0001-6322Article

Are Alzheimer's disease, hypertension, and cerebrocapillary damage related?FARKAS, E; DE VOS, R. A. I; STEUR, E. N. H. J et al.Neurobiology of aging. 2000, Vol 21, Num 2, pp 235-243, issn 0197-4580Article

Mossy fiber involvement in progressive supranuclear palsyARAI, K; BRAAK, E; DE VOS, R. A. I et al.Acta neuropathologica. 1999, Vol 98, Num 4, pp 341-344, issn 0001-6322Article

Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphismBON, M. A. M; STEUR, E. N. H. J; DE VOS, R. A. I et al.Neuroscience letters. 1999, Vol 266, Num 2, pp 149-151, issn 0304-3940Article